Monopoly Rights for Glaucoma Gold Standard FDC

Maximize Profit from Lifelong Chronic Glaucoma Market

Latoshell T Edge: Superior IOP Reduction & Compliance

Secure Exclusive Territory in Super-Specialty Segment

Low Investment, Full Technical Marketing Support
Start Your Premier Ophthalmic FDC Business Today

Home/Products /latanoprost-timolol-maleate-ip-eq-to-timlol-0-5-w-v-benzalkonium-chloride-solution-eye-drop

About the Product

Description


Latoshell T Eye Drop (Latanoprost 0.005% + Timolol 0.5%) is the gold-standard, high-profit chronic care product built for our PCD Pharma Franchise partners.

This Fixed-Dose Combination (FDC) is the most widely recognized and prescribed secondary/tertiary line treatment for Glaucoma, combining the powerful outflow enhancement of Latanoprost with the aqueous humor suppression of the Beta-Blocker Timolol. This rational combination offers maximum Intraocular Pressure (IOP) reduction in a single, once-daily drop.

Why Latoshell T is Your Key to Profit:

  1. Guaranteed Perpetual Revenue: Glaucoma treatment is mandatory and lifelong. The FDC guarantees superior patient compliance (fewer drops daily) which ensures stable, predictable, perpetual refills and excellent financial stability.

  2. Maximum Specialty Margin: Positioned as the gold-standard, specialized FDC in the critical ophthalmic segment, this product commands premium pricing and secures some of the highest profit margins in chronic eye care.

  3. Superior Clinical Value: The FDC is clinically essential for patients needing aggressive IOP lowering. This essential status drives strong, reliable specialist loyalty and consistent high-volume orders.

  4. Monopoly Opportunity: We offer exclusive rights for your area—meaning zero competition for this specific, gold-standard FDC formulation. Partner with us for full marketing support to secure high-value, recurring prescriptions and guaranteed business growth.

Contact us today to capture this max-margin chronic specialty segment!

Common side effects may include transient burning or stinging upon instillation, redness, or itching of the eyes. Rarely, systemic effects or severe allergic reactions may occur.

Ketorine Eye Drop is indicated for the relief of pain and inflammation in the eyes following surgical procedures, as well as for treating allergic conjunctivitis and other inflammatory eye disorders.

For topical use only; do not ingest. Discontinue use and consult a healthcare professional if you experience severe irritation or an allergic reaction. Always follow your healthcare provider's instructions regarding dosage and application. Ketorine Eye Drop offers a targeted approach to managing ocular pain and inflammation, contributing to better patient outcomes and enhanced comfort during recovery. Always consult with a healthcare provider before starting any new medication.

Store at room temperature, away from direct sunlight. Keep the bottle tightly closed when not in use and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Latanoprost + Timolol Maleate Eye Drops in the PCD pharma franchise market?

Latanoprost + Timolol Maleate Eye Drops are used for the management of glaucoma and ocular hypertension by effectively reducing intraocular pressure, making them a strong ophthalmology segment product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.

Why should medical distributors include these eye drops in their product range?

Medical distributors and wholesalers can benefit from consistent demand in ophthalmology clinics, eye hospitals, and glaucoma treatment centers. This combination therapy is commonly prescribed when single-drug treatment does not adequately control intraocular pressure.

Does Cafoli Lifecare offer PCD pharma franchise opportunities for this product?

Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for ophthalmic formulations with monopoly rights, quality manufacturing standards, competitive pricing, and reliable supply support for distributors and medical agencies.

What benefits do wholesalers get by partnering for this ophthalmology product?

Wholesalers and medical agencies benefit from steady specialist prescription demand, long-term glaucoma management requirements, and repeat purchases associated with chronic eye care treatment when partnering with Cafoli Lifecare.

How can I become a distributor or franchise partner for Latanoprost + Timolol Maleate Eye Drops?

Medical distributors, stockists, wholesalers, and pharma professionals interested in this ophthalmic formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, and distribution support services.